136 related articles for article (PubMed ID: 6683183)
1. A phase I trial of marcellomycin with a weekly dose schedule.
Joss RA; Kaplan S; Goldhirsch A; Varini M; Brunner KW; Cavalli F
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):455-9. PubMed ID: 6683183
[TBL] [Abstract][Full Text] [Related]
2. Clinical phase I trial of marcellomycin with a single-dose schedule.
Nicaise C; Rozencweig M; de Marneffe M; Crespeigne N; Dodion P; Piccart M; Sculier JP; Lenaz L; Kenis Y
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):449-54. PubMed ID: 6683182
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of pyrazofurin.
Salem PA; Bodey GP; Burgess MA; Murphy WK; Freireich EJ
Cancer; 1977 Dec; 40(6):2806-9. PubMed ID: 589556
[TBL] [Abstract][Full Text] [Related]
4. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
5. [Phase I and pharmacokinetic study of KRN8602, a new morpholino anthracycline].
Tabata M; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Fukutani H; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2361-6. PubMed ID: 2546503
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.
Hainsworth JD; Burris HA; Erland JB; Thomas M; Greco FA
J Clin Oncol; 1998 Jun; 16(6):2164-8. PubMed ID: 9626217
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of oral idarubicin given with a weekly schedule.
Dodion P; Finet C; Crespeigne N; Beer M; Nicaise C; Rozencweig M; Kenis Y
Invest New Drugs; 1986; 4(1):31-8. PubMed ID: 3457779
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.
Schütte J; Niederle N; Seeber S
J Cancer Res Clin Oncol; 1983; 105(2):162-5. PubMed ID: 6572190
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic study.
Karanes C; Young JD; Samson MK; Smith LB; Franco LA; Baker LH
Invest New Drugs; 1983; 1(2):173-9. PubMed ID: 6590531
[TBL] [Abstract][Full Text] [Related]
10. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lung.
Tapazoglou E; Haas CD; Samson MK; Baker LH; Pazdur R
Am J Clin Oncol; 1985 Aug; 8(4):298-301. PubMed ID: 3002165
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule.
Dodion P; Rozencweig M; Nicaise C; Piccart M; Cumps E; Crespeigne N; Kisner D; Kenis Y
Eur J Cancer Clin Oncol; 1982 Jun; 18(6):519-22. PubMed ID: 6889528
[TBL] [Abstract][Full Text] [Related]
13. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacokinetic study of rhizoxin.
Bissett D; Graham MA; Setanoians A; Chadwick GA; Wilson P; Koier I; Henrar R; Schwartsmann G; Cassidy J; Kaye SB
Cancer Res; 1992 May; 52(10):2894-8. PubMed ID: 1581905
[TBL] [Abstract][Full Text] [Related]
15. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical trial of aclacinomycin A administered on a five-consecutive-day schedule.
Woolley PV; Ayoob MJ; Levenson SM; Smith FP
J Clin Pharmacol; 1982; 22(8-9):359-65. PubMed ID: 6957420
[TBL] [Abstract][Full Text] [Related]
17. A phase of I trial of 4'-epi-Adriamycin.
Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
[TBL] [Abstract][Full Text] [Related]
18. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
[TBL] [Abstract][Full Text] [Related]
20. [Phase I study of SM-5887, a new anthracycline derivative].
Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1988 May; 15(5):1771-6. PubMed ID: 3369871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
